Patient and graft survival rates at 3 months and 1 year did not differ significantly between the two groups.Compared with p.o. treatment, i.v. administration of high TAC concentration did not have beneficial post-transplant effects on ACR incidence and severity, while increasing the incidence of viral infections in pediatric LT.